Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Probiotics Antimicrob Proteins ; 15(2): 424-440, 2023 04.
Artigo em Inglês | MEDLINE | ID: mdl-36631616

RESUMO

Mucositis is defined as inflammatory and ulcerative lesions along of the gastrointestinal tract that leads to the imbalance of the intestinal microbiota. The use of compounds with action on the integrity of the intestinal epithelium and their microbiota may be a beneficial alternative for the prevention and/or treatment of mucositis. So, the aim of this study was to evaluate the effectiveness of the association of fructo-oligosaccharides (FOS) and arginine on intestinal damage in experimental mucositis. BALB/c mice were randomized into five groups: CTL (without mucositis + saline), MUC (mucositis + saline), MUC + FOS (mucositis + supplementation with FOS-1st until 10th day), MUC + ARG (mucositis + supplementation with arginine-1st until 10th day), and MUC + FOS + ARG (mucositis + supplementation with FOS and arginine-1st until 10th day). On the 7th day, mucositis was induced with an intraperitoneal injection of 300 mg/kg 5-fluorouracil (5-FU), and after 72 h, the animals were euthanized. The results showed that association of FOS and arginine reduced weight loss and oxidative stress (P < 0.05) and maintained intestinal permeability and histological score at physiological levels. The supplementation with FOS and arginine also increased the number of goblet cells, collagen area, and GPR41 and GPR43 gene expression (P < 0.05). Besides these, the association of FOS and arginine modulated intestinal microbiota, leading to an increase in the abundance of the genera Bacteroides, Anaerostipes, and Lactobacillus (P < 0.05) in relation to increased concentration of propionate and acetate. In conclusion, the present results show that the association of FOS and arginine could be important adjuvants in the prevention of intestinal mucositis probably due to modulated intestinal microbiota.


Assuntos
Microbioma Gastrointestinal , Mucosite , Camundongos , Animais , Mucosite/tratamento farmacológico , Mucosite/metabolismo , Mucosite/patologia , Arginina/metabolismo , Intestinos , Mucosa Intestinal/metabolismo , Fluoruracila , Oligossacarídeos/farmacologia
2.
Polymers (Basel) ; 14(22)2022 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-36433032

RESUMO

Colorectal cancer has been considered a worldwide public health problem since current treatments are often ineffective. Irinotecan is a frontline chemotherapeutic agent that has dose-limiting side effects that compromise its therapeutic potential. Therefore, it is necessary to develop a novel, targeted drug delivery system with high therapeutic efficacy and an improved safety profile. Here, micellar formulations composed of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (DSPE-mPEG2k) containing irinotecan were proposed as a strategy for colorectal cancer therapy. Firstly, the irinotecan-loaded micelles were prepared using the solvent evaporation method. Then, micelles were characterized in terms of size, polydispersity, zeta potential, entrapment efficiency, and release kinetics. Cytotoxicity and in vivo antitumor activity were evaluated. The micelles showed size around 13 nm, zeta potential near neutral (-0.5 mV), and encapsulation efficiency around 68.5% (irinotecan 3 mg/mL) with a sustained drug release within the first 8 h. The micelles were evaluated in a CT26 tumor animal model showing inhibition of tumor growth (89%) higher than free drug (68.7%). Body weight variation, hemolytic activity, hematological, and biochemical data showed that, at the dose of 7.5 mg/kg, the irinotecan-loaded micelles have low toxicity. In summary, our findings provide evidence that DSPE-mPEG2k micelles could be considered potential carriers for future irinotecan delivery and their possible therapeutic application against colorectal cancer.

3.
Food Res Int ; 151: 110897, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-34980418

RESUMO

High-fat diets seem to have a negative influence on the development of obesity and the processes associated with low-grade chronic systemic inflammation. In recent years, partial hydrogenated oil, rich in trans isomers, has been associated with deleterious health effects. It has been replaced by interesterified fat (IF). However, there is no evidence whether IF ingestion can exert adverse effects on the intestinal mucosa. Thus, this study aimed to evaluate the effect of IF on the intestinal mucosa of male Swiss mice fed a normal or high-fat diet, focusing on its effects on intestinal permeability and bacterial translocation and its possible damage to the intestinal epithelium. The animals were divided into 4 groups: Control (C) and Interesterified Control (IC) groups (10 En% lipids from unmodified fat or interesterified fat, respectively) and High Fat (HF) and Interesterified High Fat (IHF) groups (45 En% lipids from unmodified fat or interesterified fat, respectively). Compare to C, the IC, HF, and IHF groups presented flattened epithelium, a shorter villi length and a lower percentage of goblet cells, less mucin 2, an increased oxidative stress and more inflammatory cells, higher IL-1ß, IL-17, and IL-23 levels. These groups also presented increased intestinal permeability and gene expression of the protein claudin 2, while JAM-A and claudin 1 gene expression was reduced. IC and IHF increased IL-6 levels while reducing occludin expression. In addition, the IC group also presented a mucosa with lesions of low intensity in the ileum, an increased mucin 5ac, TNF-α levels, and reduced occludin expression in the distal jejunum. Moreover, there was a significant increase in bacterial translocation in the IC group to blood, liver, and lungs, while HF and IHF groups presented bacterial translocation which was restricted to the mesenteric lymph nodes. In summary, our results supported the hypothesis that IF added to a normolipidic diet can be considered harmful or even worse when compared to a HF.


Assuntos
Translocação Bacteriana , Ácidos Graxos , Animais , Dieta Hiperlipídica/efeitos adversos , Expressão Gênica , Masculino , Camundongos , Óleo de Palmeira , Permeabilidade , Proteínas de Junções Íntimas/genética
4.
Nat Prod Res ; 36(16): 4221-4226, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34491148

RESUMO

Piper methysticum G. Forst, popularly known as kava, is a traditional medicinal plant widely used for the treatment of anxiety and insomnia. The aim of this study was to investigate new therapeutic applications of this plant. Nociceptive response induced by heat (hot-plate) was used as pain model. Susceptibility of different strains to kava ethanolic dried extracts was evaluated by broth microdilution method. Acute oral toxicity was performed according to Organisation for Economic Cooperation and Development (OECD) guideline. Administration of kava dried extracts and kavain inhibited the nociceptive response in the hot-plate model and did not affect the time mice spent in the rota-rod apparatus. The samples showed no significant antibacterial activity, however slight antifungal activity was verified. The extracts may be considered of low oral acute toxicity. Kava extracts exhibited promising antinociceptive activity in model of nociceptive pain, which should be deeper explored as a new therapeutic application of kava.


Assuntos
Anti-Infecciosos , Kava , Analgésicos/farmacologia , Animais , Camundongos , Extratos Vegetais/farmacologia , Pironas
5.
Biomed Pharmacother ; 133: 111012, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33254017

RESUMO

The beneficial effects of prebiotic, such as fructo-oligosaccharides (FOS), in intestinal inflammation have been demonstrated in several studies. Herein, we evaluate whether joint treatment with FOS, both before and during mucositis, had additional beneficial effects and investigated the mechanisms underlying in the action of FOS on the intestinal barrier. BALB/c mice were randomly divided into five groups: CTR (without mucositis + saline solution), FOS (without mucositis + 6 % FOS), MUC (mucositis + saline solution), PT (mucositis + 6 % FOS supplementation before disease induction), and TT (mucositis + 6 % FOS supplementation before and during disease induction). Mucositis was induced by intraperitoneal injection (300 mg/kg) of 5-fluorouracil (5-FU). After 72 h, the animals were euthanized and intestinal permeability (IP), tight junction, bacterial translocation (BT), histology and morphometry, and immunoglobulin A secretory (sIgA), inflammatory infiltrate, and production of short-chain fatty acids (acetate, butyrate and propionate) were evaluated. The MUC group showed an increase in the IP, BT, and inflammatory infiltrate but a decrease in the tight junction expression and butyrate and propionate levels (P < 0.05). In the PT and TT groups, FOS supplementation maintained the IP, tight junction expression, and propionate concentration within physiologic levels, increased butyrate levels, and reduced BT and inflammatory infiltrate (P < 0.05). Total treatment with FOS (TT group) was more effective in maintaining histological score, morphometric parameters, and sIgA production. Thus, total treatment (prophylactic and therapeutic supplementation) with FOS was more effective than pretreatment alone, in reducing 5-FU-induced damage to the intestinal barrier.


Assuntos
Bactérias/efeitos dos fármacos , Ácidos Graxos Voláteis/metabolismo , Microbioma Gastrointestinal/efeitos dos fármacos , Íleo/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Mucosite/induzido quimicamente , Oligossacarídeos/farmacologia , Prebióticos , Junções Íntimas/efeitos dos fármacos , Acetatos/metabolismo , Animais , Bactérias/metabolismo , Translocação Bacteriana/efeitos dos fármacos , Butiratos/metabolismo , Modelos Animais de Doenças , Fluoruracila , Íleo/metabolismo , Íleo/microbiologia , Íleo/patologia , Imunoglobulina A Secretora/metabolismo , Mediadores da Inflamação/metabolismo , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiologia , Mucosa Intestinal/patologia , Masculino , Camundongos Endogâmicos BALB C , Mucosite/metabolismo , Mucosite/microbiologia , Mucosite/patologia , Permeabilidade , Propionatos/metabolismo , Junções Íntimas/metabolismo , Junções Íntimas/microbiologia , Junções Íntimas/patologia
6.
Toxicol Appl Pharmacol ; 352: 162-169, 2018 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-29864484

RESUMO

Doxorubicin (DOX) is widely used in cancer treatment, however, the use of this drug is often limited due to its cardiotoxic side effects. In order to avoid these adverse effects, the encapsulation of DOX into nanosystems has been used in the last decades. In this context, pH-sensitive liposomes have been shown promising for delivering cytotoxic agents into tumor cells, however, the lack of information about in vivo toxicity of this nanocarrier has impaired translational studies. Therefore, the aim of this work was to investigate the acute toxicity and cardiotoxicity of DOX-loading pH-sensitive liposomes (SpHL-DOX). To achieve this, female BALB/c mice, after intravenous administration, were monitored by means of clinical, laboratory, histopathological and electrocardiographic (ECG) analyses. Results indicate that SpHL was able to prevent renal toxicity and the hepatic injury was less extensive than free DOX. In addition, lower body weight loss was associated with less ECG QT interval prolongation to animals receiving SpHL-DOX (14.6 ±â€¯5.2%) compared to animals receiving free DOX (35.7 ±â€¯4.0%) or non-pH-sensitive liposomes (nSpHL-DOX) (47.0 ±â€¯9.8%). These results corroborate with SpHL-DOX biodistribution studies published by our group. In conclusion, the SpHL-DOX showed less toxic effects on mice compared to free DOX or nSpHL-DOX indicating that SpHL-DOX is a promising strategy to reduce the serious cardiotoxic effects of DOX.


Assuntos
Antibióticos Antineoplásicos/toxicidade , Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Doxorrubicina/toxicidade , Avaliação Pré-Clínica de Medicamentos , Cardiopatias/prevenção & controle , Nefropatias/prevenção & controle , Animais , Antibióticos Antineoplásicos/administração & dosagem , Antibióticos Antineoplásicos/química , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Doença Hepática Induzida por Substâncias e Drogas/patologia , Preparações de Ação Retardada , Doxorrubicina/administração & dosagem , Doxorrubicina/química , Composição de Medicamentos , Feminino , Coração/efeitos dos fármacos , Cardiopatias/induzido quimicamente , Cardiopatias/patologia , Concentração de Íons de Hidrogênio , Injeções Intravenosas , Rim/efeitos dos fármacos , Rim/patologia , Nefropatias/induzido quimicamente , Nefropatias/patologia , Lipossomos , Fígado/efeitos dos fármacos , Fígado/patologia , Camundongos Endogâmicos BALB C , Miocárdio/patologia
7.
Biomed Pharmacother ; 103: 1567-1576, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29864944

RESUMO

BACKGROUND: Studies have showed the protective effects of conjugated linoleic acid (CLA) on intestinal epithelium, modulating host immune and inflammatory responses on intestinal diseases. OBJECTIVE: To evaluate the preventive effects of CLA on the intestinal mucositis induced by 5-FU in a murine model. METHODS: Sixty-four BALB/c mice were randomly divided into four groups: Control (CTL), fed a standard chow diet; CLAs, fed a diet supplemented with CLA; Mucositis (5-FU), fed a standard chow diet and underwent mucositis induction and CLAs 5-FU, fed a diet supplemented with CLA and underwent mucositis induction. Mucositis was induced by intraperitoneal injection of 300 mg/kg 5-FU. After 72 h, the animals were euthanized and intestinal permeability, bacterial translocation, inflammatory mediators, and intestinal histology were evaluated. RESULTS: Mice in the CLAs 5-FU group showed reduced weight loss compared to those in the 5-FU group (p < 0.005). Furthermore, the results also showed that the treatment with CLA reduced intestinal permeability, bacterial translocation, and biomarkers of inflammatory response besides minor damage to ZO-1 and occludin with maintenance of the integrity of the intestinal epithelium and a favorable balance between the inflammatory and regulatory cytokines. CONCLUSION: This study suggests that CLA reduced the adverse effects from 5-FU administration on the intestinal mucosa.


Assuntos
Fluoruracila/efeitos adversos , Intestinos/patologia , Ácidos Linoleicos Conjugados/uso terapêutico , Mucosite/tratamento farmacológico , Mucosite/prevenção & controle , Animais , Translocação Bacteriana/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Quimiocinas/metabolismo , Modelos Animais de Doenças , Comportamento Alimentar , Imunoglobulina A/metabolismo , Inflamação/patologia , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/patologia , Ácidos Linoleicos Conjugados/farmacologia , Masculino , Camundongos Endogâmicos BALB C , Mucosite/microbiologia , Mucosite/patologia , Distribuição Tecidual/efeitos dos fármacos
8.
JPEN J Parenter Enteral Nutr ; 40(8): 1131-1139, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-25855577

RESUMO

BACKGROUND: Imbalances in a variety of factors, including genetics, intestinal flora, and mucosal immunity, can contribute to the development of ulcerative colitis and its side effects. This study evaluated the effects of pretreatment or treatment with arginine by oral administration on intestinal permeability, bacterial translocation (BT), and mucosal intestinal damage due to colitis. METHODS: C57BL/6 mice were distributed into 4 groups: standard diet and water (C: control group), standard diet and dextran sodium sulfate (DSS) solution (Col: colitis group), 2% L-arginine supplementation for 7 days prior to DSS administration and during disease induction (PT: pretreated group), and 2% L-arginine supplementation during disease induction (T: treated group). Colitis was induced by administration of 1.5% DSS for 7 days. After 14 days, intestinal permeability and BT were evaluated; colons were collected for histologic analysis and determination of cytokines; feces were collected for measurement of immunoglobulin A (IgA). RESULTS: The Col group showed increased intestinal permeability (C vs Col: P < .05) and BT (C vs Col: P < .05). In the arginine-supplemented groups (PT and T), this amino acid tended to decrease intestinal permeability. Arginine decreased BT to liver during PT (P < .05) and to blood, liver, spleen, and lung during T (P < .05). Histologic analysis showed that arginine preserved the intestinal mucosa and tended to decreased inflammation. CONCLUSIONS: Arginine attenuates weight loss and BT in mice with colitis.


Assuntos
Arginina/farmacologia , Translocação Bacteriana/efeitos dos fármacos , Colite/tratamento farmacológico , Redução de Peso/efeitos dos fármacos , Administração Oral , Animais , Colite/induzido quimicamente , Sulfato de Dextrana , Fezes/química , Feminino , Imunoglobulina A/análise , Absorção Intestinal/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Intestinos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Permeabilidade
9.
J Ethnopharmacol ; 165: 29-38, 2015 May 13.
Artigo em Inglês | MEDLINE | ID: mdl-25683298

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Arrabidaea chica (Bignoniacea) has been used in popular medicine in Brazil to treat inflammation, skin diseases and leukemia. This work aimed to investigate the anti-inflammatory and antitumoral activities of the A. chica aqueous (AE) and ethanol (EE) extracts. MATERIALS AND METHODS: The murine sponge model was used to evaluate the anti-inflammatory and antiangiogenic activities of AE and EE. Accumulation of neutrophil and macrophage in the implants were determined by assaying myeloperoxidase and N-acetyl-glucosaminidase activities and the neovascularization evaluated by the amount of hemoglobin present in the implant using the Drabkin method. The antitumoral activity was evaluated using the MTT colorimetric method against Jurkat, HL60 and MCF-7 cells. Semi-purified fractions F1-F4 from the EE extract were obtained by a liquid-liquid solvent extraction method and their in vitro anti-proliferative effects were also investigated. RESULTS: Ethanol and aqueous extracts of A. chica decreased neutrophil accumulation and hemoglobin content in the sponge implants without altering the level of cytokines (IL-2, IL- 4, IL-5, IFN-γ, TNF-α and VEGF) and the albumin/globulin ratio in the serum of treated animals. There was no sign of toxicity (clinical, laboratory or histopathology). The ethanol extract presented antiproliferative activity (IC50 21.5-36.3 µg/mL) against HL60 and Jurkat cell lineages and proapoptotic activity at 50 µg/mL in HL60 cells. The fraction F1 also demonstrated significant antiproliferative activity (IC50 38.5 µg/mL) and proapoptotic activity against HL60 cells in a dose dependent manner. CONCLUSIONS: Aqueous and ethanol extracts of A. chica attenuate the inflammatory and angiogenic components of the subcutaneous fibrovascular tissue induced by the synthetic matrix in mice. In addition, the ethanol extract from Arrabidaea chica and its fraction F1 presented in vitro antiproliferative activity and could be useful for developing potential chemopreventive substances.


Assuntos
Anti-Inflamatórios/farmacologia , Antineoplásicos Fitogênicos/farmacologia , Bignoniaceae , Neovascularização Patológica/tratamento farmacológico , Extratos Vegetais/farmacologia , Animais , Bignoniaceae/química , Proliferação de Células/efeitos dos fármacos , Citocinas/biossíntese , Células HL-60/efeitos dos fármacos , Humanos , Células Jurkat/efeitos dos fármacos , Células MCF-7/efeitos dos fármacos , Masculino , Camundongos , Folhas de Planta/química , Fator de Necrose Tumoral alfa/biossíntese , Fator A de Crescimento do Endotélio Vascular/biossíntese
10.
BMC Complement Altern Med ; 12: 40, 2012 Apr 11.
Artigo em Inglês | MEDLINE | ID: mdl-22494818

RESUMO

BACKGROUND: In a previous study, we showed that a saponin mixture isolated from the roots of Ampelozizyphus amazonicus Ducke (SAPAaD) reduces urine excretion in rats that were given an oral loading of 0.9 % NaCl (4 ml/100 g body weight). In the present study, we investigated whether atrial natriuretic peptides (ANP) and renal ATPases play a role in the SAPAaD- induced antidiuresis in rats. METHODS: To evaluate the effect of SAPAaD on furosemide-induced diuresis, Wistar rats (250-300 g) were given an oral loading of physiological solution (0.9 % NaCl, 4 ml/100 g body weight) to impose a uniform water and salt state. The solution containing furosemide (Furo, 13 mg/kg) was given 30 min after rats were orally treated with 50 mg/kg SAPAaD (SAPAaD + Furo) or 0.5 ml of 0.9 % NaCl (NaCl + Furo). In the SAPAaD + NaCl group, rats were pretreated with SAPAaD and 30 min later they received the oral loading of physiological solution. Animals were individually housed in metabolic cages, and urine volume was measured every 30 min throughout the experiment (3 h). To investigate the role of ANP and renal Na(+) pumps on antidiuretic effects promoted by SAPAaD, rats were given the physiological solution (as above) containing SAPAaD (50 mg/kg). After 90 min, samples of urine and blood from the last 30 min were collected. Kidneys and atria were also removed after previous anesthesia. ANP was measured by radioimmunoassay (RIA) and renal cortical activities of Na(+)- and (Na(+),K(+))-ATPases were calculated from the difference between the [32P] Pi released in the absence and presence of 1 mM furosemide/2 mM ouabain and in the absence and presence of 1 mM ouabain, respectively. RESULTS: It was observed that SAPAaD inhibited furosemide-induced diuresis (at 90 min: from 10.0 ± 1.0 mL, NaCl + Furo group, n = 5, to 5.9 ± 1.0 mL, SAPAaD + Furo group n = 5, p < 0.05), increased both Na(+)-ATPase (from 25.0 ± 5.9 nmol Pi.mg(-1).min(-1), control, to 52.7 ± 8.9 nmol Pi.mg(-1).min(-1), p < 0.05) and (Na(+),K(+))-ATPase (from 47.8 ± 13.3 nmol Pi.mg(-1).min(-1), control, to 79.8 ± 6.9 nmol Pi .mg(-1).min(-1), p < 0.05) activities in the renal cortex. SAPAaD also lowered urine ANP (from 792 ± 132 pg/mL, control, to 299 ± 88 pg/mL, p < 0.01) and had no effect on plasma or atrial ANP. CONCLUSION: We concluded that the SAPAaD antidiuretic effect may be due to an increase in the renal activities of Na(+)- and (Na(+),K(+))-ATPases and/or a decrease in the renal ANP.


Assuntos
Fator Natriurético Atrial/urina , Rim/efeitos dos fármacos , Extratos Vegetais/farmacologia , Rhamnaceae/química , Saponinas/farmacologia , ATPase Trocadora de Sódio-Potássio/metabolismo , Micção/efeitos dos fármacos , Adenosina Trifosfatases/urina , Animais , Proteínas de Transporte de Cátions/urina , Diurese/efeitos dos fármacos , Inibidores Enzimáticos , Furosemida , Rim/metabolismo , Masculino , Ouabaína , Ratos , Ratos Wistar , Cloreto de Sódio/urina
11.
Biosci. j. (Online) ; 26(1): 121-127, jan.-feb. 2010. ilus
Artigo em Português | LILACS | ID: lil-545382

RESUMO

As Metaloproteinases de Matriz (MMPs) podem exercer importantes funções na remodelagem fisiológica e patológica da matriz extracelular. Elas são implicadas na progressão tumoral de muitas malignidades humanas interferindo em eventos angiogênicos, invasivos e metastáticos. Produtos obtidos de algumas plantas têm sido consistentemente associados a funções neoplásicas, possivelmente por reproduzir a atividade neutralizadora dos inibidores teciduais (TIMPs) das MMPs. No presente trabalho, investigou-se a inibição da atividade gelatinolítica das MMPs -2 e -9 por extratos aquosos (EA) de Aloe vera, chá preto e Annona muricata diluídos em tampão de ativação (TA, com cálcio). A atividade proteolítica das MMPs foi avaliada em ensaios zimográficos. Para avaliar o efeito inibitório dos produtos testados, géis foram seccionados e incubados em soluções contendo o TA e os EA em três diluições seriadas. Associação indireta foi observada entre o EA de A. vera e chá preto e a inibição da atividade de MMP-2. EA de A. muricata exerceu pequeno efeito inibitório na MMP-2 nas duas menores diluições. A atividade de MMP-9 foi consistentemente neutralizada por todos os EA testados, de forma dose-dependente. Estes resultados sugerem que os efeitos antitumorais verificados paraos EA de A. vera, A. muricaca, e chá preto podem ser explicados parcialmente por sua atividade inibitória sobre as MMP-2 e -9.


Matrix metalloproteinases may exert important roles in both physiologic and pathologicextracellular matrix remodeling. They have been implicated in tumoral progression of many human malignancies interfering on angiogenic, invasive, and metastatic events. Products obtained from some plants have been consistently associated to anti-neoplastic roles, possibly by reproducing the neutralizing activity of tissue inhibitors over MMPs. In the present work, we investigate the inhibition of the MMP-2 and -9 gelatinolytic activity by Aloe vera, black tea, and Annona muricata aqueous extracts (AE) diluted in activation buffer (AB, with calcium). The proteolytic activity of MMP was evaluated on zymographic assays. To evaluate the inhibitory effect of the tested products, gels were sectioned and incubated in the solutions containing the AB and AE from three serial dilutions. Indirect association was observed between the dilution of A. vera and black tea and MMP-2 activity inhibition. A. muricata exerted only small inhibition on MMP-2 effect in the two smallest dilutions. The MMP-9 activity was consistently neutralized by all of the natural solutions in a dose-dependent way. The present results suggest that the antitumoral effects verified for A. vera, A. muricaca, and black tea AE may be partially explained by their inhibitory activity on MMP.


Assuntos
Annona , Camellia sinensis , Metaloproteinases da Matriz , Plantas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA